Yen‐Hung Lin

8.7k total citations · 1 hit paper
278 papers, 5.2k citations indexed

About

Yen‐Hung Lin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yen‐Hung Lin has authored 278 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Endocrinology, Diabetes and Metabolism, 132 papers in Surgery and 124 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yen‐Hung Lin's work include Hormonal Regulation and Hypertension (130 papers), Adrenal and Paraganglionic Tumors (90 papers) and Blood Pressure and Hypertension Studies (54 papers). Yen‐Hung Lin is often cited by papers focused on Hormonal Regulation and Hypertension (130 papers), Adrenal and Paraganglionic Tumors (90 papers) and Blood Pressure and Hypertension Studies (54 papers). Yen‐Hung Lin collaborates with scholars based in Taiwan, United States and China. Yen‐Hung Lin's co-authors include Vin‐Cent Wu, Yi‐Lwun Ho, Kwan‐Dun Wu, Shih‐Chieh Chueh, Yung‐Ming Chen, Chi‐Sheng Hung, Lian‐Yu Lin, Hsien‐Li Kao, Shuo‐Meng Wang and Yen‐Wen Wu and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Yen‐Hung Lin

261 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗

2020 180 citations Paolo Mulatero, Silvia Monticone et al. Journal of Hypertension profile →

Peers

Yen‐Hung Lin

SURGE

EDM

CCM

PRM

Jean‐Jacques Mourad France

María Lorenza Muiesan Italy

Bernhard M. W. Schmidt Germany

Dario Pitocco Italy

Satoshi Miyata Japan

Arturo Pujia Italy

Malcolm West Australia

Vin‐Cent Wu Taiwan

Maarten W. Nijsten Netherlands

John Lekakis Greece

Jean‐Jacques Mourad France

Yen‐Hung Lin

2.0k ×0.9

SURGE

1.9k ×0.8

EDM

3.1k ×1.8

CCM

891 ×1.3

PRM

702 ×1.2

Citations per year, relative to Yen‐Hung Lin Yen‐Hung Lin (= 1×) peers Jean‐Jacques Mourad

Countries citing papers authored by Yen‐Hung Lin

Since Specialization

Citations

This map shows the geographic impact of Yen‐Hung Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Hung Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Hung Lin more than expected).

Fields of papers citing papers by Yen‐Hung Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Hung Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Hung Lin. The network helps show where Yen‐Hung Lin may publish in the future.

Co-authorship network of co-authors of Yen‐Hung Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Hung Lin. A scholar is included among the top collaborators of Yen‐Hung Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Hung Lin. Yen‐Hung Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Yi‐Hsuan, Chia‐Wen Lu, Hao‐Min Cheng, et al.. (2025). Definition, prevalence, and economic impacts of hypertension on the elderly population. Journal of the Formosan Medical Association. 124. S4–S9. 1 indexed citations

Lin, Liang‐Yu, Yen‐Hung Lin, Shih‐Chieh Chueh, et al.. (2025). Universal Screening for Primary Aldosteronism in Hypertensive Patients: A 2025 Taipei Positional Paper. Journal of Clinical Hypertension. 27(9). e70102–e70102.

Tsai, Cheng‐Hsuan, Jenifer M. Brown, Andrew J Newman, et al.. (2025). ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism. Hypertension. 82(6). 1046–1055. 4 indexed citations

Wang, Wei‐Ting, Leay‐Kiaw Er, Chien‐Wei Huang, et al.. (2024). Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review. Hypertension Research. 47(5). 1103–1119. 5 indexed citations

Chen, Joseph C. Y., Chiao‐Ling Tsai, Chia‐Ter Chao, et al.. (2024). Serial changes of 99mTc- pyrophosphate uptake in patients with hereditary transthyretin amyloid cardiomyopathy treated with tafamidis. European Heart Journal. 45(Supplement_1).

Lin, Chun-Hsien, Chia‐Wen Lu, Tai‐Shuan Lai, et al.. (2024). Blood pressure targets, medication consideration and special concerns in elderly hypertension part I: General principles and special considerations. Journal of the Formosan Medical Association. 124. S42–S48.

Chen, Zheng‐Wei, Chieh‐Kai Chan, Chia-Hung Lin, et al.. (2024). Evaluations of secondary hypertension and laboratory data in the elderly population. Journal of the Formosan Medical Association. 124. S24–S31. 1 indexed citations

Chang, Yu‐Ling, Guan‐Yuan Chen, Bo‐Ching Lee, et al.. (2023). Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC–MS/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol. Hypertension Research. 46(8). 1983–1994. 6 indexed citations

Chang, Yu‐Ling, Bo‐Ching Lee, Ching‐Chu Lu, et al.. (2023). Strategies for subtyping primary aldosteronism. Journal of the Formosan Medical Association. 123. S114–S124. 4 indexed citations

10.

Lin, Weiqin, Pairoj Chattranukulchai, Alex Pui‐Wai Lee, et al.. (2022). Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia. Clinical Cardiology. 45(9). 898–907. 4 indexed citations

11.

Tsai, Cheng‐Hsuan, Che‐Wei Liao, Xue-Ming Wu, et al.. (2022). Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism: a cross-sectional study with follow-up data. European Journal of Endocrinology. 187(1). 197–208. 19 indexed citations

12.

Liao, Hung‐Wei, et al.. (2021). Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism. Biomedicines. 9(12). 1816–1816. 4 indexed citations

13.

Chang, Yi‐Yao, Chien‐Ting Pan, Zheng‐Wei Chen, et al.. (2021). KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated with a Greater Recovery of Arterial Stiffness. Cancers. 13(17). 4313–4313. 6 indexed citations

14.

Mulatero, Paolo, Silvia Monticone, Jaap Deinum, et al.. (2020). Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗. Journal of Hypertension. 38(10). 1919–1928. 180 indexed citations breakdown →

15.

Hung, Chi‐Sheng, Yen‐Hung Lin, Ying‐Hsien Chen, et al.. (2016). Mortality Benefit of a Fourth-Generation Synchronous Telehealth Program for the Management of Chronic Cardiovascular Disease: A Longitudinal Study. Journal of Medical Internet Research. 18(5). e102–e102. 18 indexed citations

16.

Lin, Yen‐Hung, Xin Lai, Yuan Xu, et al.. (2012). Association among serum uric acid, cardiovascular risk, and arterial stiffness: a cross-sectional study in She ethnic minority group of Fujian Province in China.. PubMed. 35(3). 290–7. 10 indexed citations

17.

Wu, Vin‐Cent, Chia‐Ter Chao, Chin‐Chi Kuo, et al.. (2012). Diagnosis and Management of Primary Aldosteronism. 26(3). 111–120. 11 indexed citations

18.

Wu, Vin‐Cent, Shyh‐Chyi Lo, Yuh‐Lien Chen, et al.. (2011). Endothelial Progenitor Cells in Primary Aldosteronism: A Biomarker of Severity for Aldosterone Vasculopathy and Prognosis. The Journal of Clinical Endocrinology & Metabolism. 96(10). 3175–3183. 65 indexed citations

19.

Wang, Yu-Chen, Jen‐Kuang Lee, Vin‐Cent Wu, et al.. (2008). The Serum Concentrations of Procollagen Propeptides in Hypertensive Patients with or Without Diabetes. Zhōnghuá mínguó xīnzàngxué huì zázhì. 24(4). 198–203. 3 indexed citations

20.

Lin, Yen‐Hung, Jou‐Wei Lin, Ron‐Bin Hsu, Chi‐Hsiang Huang, & Hsien‐Li Kao. (2004). Coronary Stent Strut Avulsion and Cutting Balloon Fracture in Treating In-stent Restenosis. Zhōnghuá mínguó xīnzàngxué huì zázhì. 20(4). 256–260. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact